Receptor-dependent protein activation without a receptor

Activation of G-Proteins was previously thought to be exclusively triggered by extracellular stimuli. Now Dr. Jrgen Knoblich and his group at the Research Institute of Molecular Pathology, Vienna (Austria), provide in vivo evidence for G-Protein activation solely by an intracellular protein.

"G-Protein activation was predominantly seen as a "relay station integrating extracellular signals via membrane spanning receptors with intracellular responses. The central role of this activation in cell responses to hormones and neurotransmitters makes G-proteins a major target for a wide range of powerful pharmaceuticals in humans. However, we now believe that a cellular mechanism exists which can activate these key proteins without extracellular stimulation. This fundamental insight could help gaining better understanding of disease mechanisms and will aid the development of novel therapies comments Dr. Knoblich.

Published in tomorrows issue of Cell (Vol. 107/2). the work by Knoblich describes a role for the cellular protein Pins (Partner of Inscuteable) in the localised activation of G-proteins in asymmetrically dividing cells of the developing Drosophila nervous system. Autonomous activation of G-proteins is shown to be part of a synchronised interaction of several proteins in differentiating neuroblasts. The receptor-independent activation of G-proteins is believed to support cellular polarity not only in neuroblasts but also in precursor cells of sensory organs (SOPs). Such establishment and maintenance of cellular polarity is essential for correct differentiation of these cells after delamination from adjacent tissue.

Previous work by Stephen Lanier and colleagues at the Medical University of South Carolina showed that Pins are conserved in humans and can activate G-proteins under controlled in vitro conditions. Taken together with the in vivo data from Drosophila reported here it is believed that receptor-independent G-protein activation plays an

Contact: Heidemarie Hurtl
PR&D Public Relations for Research & Development

Page: 1 2

Related biology news :

1. New molecular link key to cellular proteins involved in cancer progression, other diseases
2. Researchers identify protein promoting vascular tumor growth
3. UCI scientists successfully target key HIV protein; breakthrough may lead to new drug therapies
4. Experimental drug shown to block mutant protein causing blood disease
5. Loss of the neuronal adhesion protein d-catenin leads to severe cognitive dysfunction
6. Images of tail of protein needed for cell multiplication suggest anticancer drug targets
7. New dye directly reveals activated proteins in living cells
8. Disruption of protein-folding causes neurodegeneration, mental retardation
9. A new protein is discovered to play a key role in cancer progression
10. Optimizing proteins death domain halts leukemia in laboratory study
11. Stuck on you: Scientists lay bare secrets of bacterial attachment proteins

Post Your Comments:

(Date:12/14/2018)... ... December 14, 2018 , ... uBiome, the leader in ... for Microbiome-Derived Diagnostics and Therapeutics” by the US Patent and Trademark Office on ... is an invention by uBiome collaborators Dr. Zachary Apte, Dr. Daniel Almonacid, Dr. ...
(Date:12/13/2018)... ... 2018 , ... Illumina, Kaiser Permanente, ResMed and Aetna were just a few ... and cooking events company has hosted an impressive guest list of Fortune 500 businesses, ... Each group who visits receives a completely customized experience, right down to the menu ...
(Date:12/10/2018)... , ... December 10, 2018 , ... ... strategic alliance to advance their shared goal of accelerating the development of the ... scale-up bioprocess systems to TRT’s core technology around human umbilical cord perivascular cells ...
Breaking Biology News(10 mins):
(Date:1/10/2019)... ... January 08, 2019 , ... ... announced today that SAGICO will be represented at the 37th Annual J.P. ... Healthcare Conference is the largest and most informative healthcare investment symposium in ...
(Date:1/8/2019)... ... January 07, 2019 , ... ... members into Noninvasix. This represents the second investment AngelMD has made into Noninvasix ... morbidity, Noninvasix is developing a patient monitor to directly, accurately, and noninvasively measure ...
(Date:1/7/2019)... ... January 07, 2019 , ... Kainos Medicine Inc. today ... drug candidate, code-named "KM-819." KM-819 is an orally active small molecule that ... South Korea. , This Phase 1 randomized, double-blind, placebo-controlled dose-escalation study was ...
(Date:1/4/2019)... ... January 01, 2019 , ... uBiome, the ... World Economic Forum Annual Meeting January 22-25, 2019 held in Davos-Klosters, Switzerland following ... World Economic Forum Annual Meeting brings together leaders of global society–the heads and ...
Breaking Biology Technology:
Cached News: